NR2F1 and breast cancer: We show in this paper that in all large human breast cancer gene expression studies examined, triple-negative (aggressive, therapy-resistant) and histological grade 3 (poorly differentiated, highly proliferative) breast cancers display lower NR2F1 transcript levels as compared with ‘receptor-positive’ and histological grade 1/2 breast cancers, respectively.